A Study to Assess Variation in Potential Biomarkers in Friedreich Ataxia

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

January 14, 2020

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Friedreich Ataxia
Interventions
DIAGNOSTIC_TEST

Buccal Swabs and Blood Draws

Buccal Swabs - Frataxin \& specific RNA markers Blood Draws - Lipid panel, Uric Acid, Protein Marker Analysis and PAX Gene RNA Analysis

Trial Locations (1)

19104

The Children's Hospital of Philadelphia, Philadelphia

Sponsors
All Listed Sponsors
collaborator

Children's Hospital of Philadelphia

OTHER

lead

Larimar Therapeutics, Inc.

INDUSTRY

NCT04255680 - A Study to Assess Variation in Potential Biomarkers in Friedreich Ataxia | Biotech Hunter | Biotech Hunter